源自疾病控制与预防中心。更新：利福平与吡嗪酰胺治疗潜伏性结核感染相关的致命性和严重肝损伤。 - Suppr

Suppr

超能文献

From the Centers for Disease Control and Prevention. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.

出版信息

JAMA. 2002 Dec 18;288(23):2967. doi: 10.1001/jama.288.23.2967-jwr1218-6-1.

DOI:10.1001/jama.288.23.2967-jwr1218-6-1

PMID:12492097

Abstract

摘要

相似文献

From the Centers for Disease Control and Prevention. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.

JAMA. 2002 Dec 18;288(23):2967. doi: 10.1001/jama.288.23.2967-jwr1218-6-1.

Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.

MMWR Morb Mortal Wkly Rep. 2002 Nov 8;51(44):998-9.

From the Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with Rifampin and Pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.

JAMA. 2001 Sep 26;286(12):1445-6.

From the Centers for Disease Control and Prevention. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.

JAMA. 2001;285(20):2572-3.

Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.

MMWR Morb Mortal Wkly Rep. 2001 Aug 31;50(34):733-5.

National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection.

Clin Infect Dis. 2005 Oct 15;41(8):1125-33. doi: 10.1086/444463. Epub 2005 Sep 9.

Rifampin and pyrazinamide for treatment of latent tuberculosis infection.

Clin Infect Dis. 2006 Mar 15;42(6):892; author reply 892-3. doi: 10.1086/500458.

Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.

MMWR Morb Mortal Wkly Rep. 2001 Apr 20;50(15):289-91.

Severe hepatotoxicity associated with rifampin-pyrazinamide preventative therapy requiring transplantation in an individual at low risk for hepatotoxicity.

Clin Infect Dis. 2003 Jun 15;36(12):e158-61. doi: 10.1086/375072. Epub 2003 Jun 6.

Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection.

Chest. 2003 Mar;123(3):967. doi: 10.1378/chest.123.3.967.

引用本文的文献

Liver and pancreatic injury induced by antituberculous therapy.

Dig Dis Sci. 2007 Nov;52(11):3275-81. doi: 10.1007/s10620-005-9017-9. Epub 2007 Feb 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

From the Centers for Disease Control and Prevention. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.

出版信息

JAMA. 2002 Dec 18;288(23):2967. doi: 10.1001/jama.288.23.2967-jwr1218-6-1.

DOI:10.1001/jama.288.23.2967-jwr1218-6-1

PMID:12492097

Abstract

摘要